Pratik S Bhojnagarwala

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Renal Cell Carcinoma

Inflammatory Response

Top Venues

Journal for immunotherapy of cancer

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan P O'Connell, Kevin Liaw, Nils Wellhausen, Christopher A Chuckran, Pratik S Bhojnagarwala, Devivasha Bordoloi, Daniel H Park, Nicholas Shupin, Daniel Kulp, Carl H June, David Weiner
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma. Journal for immunotherapy of cancer 12 (6) (2024)
Ryan P O'Connell, Kevin Liaw, Nils Wellhausen, Christopher A Chuckran, Pratik S Bhojnagarwala, Devivasha Bordoloi, Daniel H Park, Nicholas Shupin, Daniel Kulp, Carl H June, David Weiner
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma. Journal for immunotherapy of cancer 12 (6) (2024)
Ryan P O'Connell, Kevin Liaw, Nils Wellhausen, Christopher A Chuckran, Pratik S Bhojnagarwala, Devivasha Bordoloi, Daniel H Park, Nicholas Shupin, Daniel Kulp, Carl H June, David Weiner
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma. Journal for immunotherapy of cancer 12 (6) (2024)
Ryan P O'Connell, Kevin Liaw, Nils Wellhausen, Christopher A Chuckran, Pratik S Bhojnagarwala, Devivasha Bordoloi, Daniel H Park, Nicholas Shupin, Daniel Kulp, Carl H June, David Weiner
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma. Journal for immunotherapy of cancer 12 (6) (2024)
Devivasha Bordoloi, Abhijeet J Kulkarni, Opeyemi S Adeniji, Maria Betina Pampena, Pratik S Bhojnagarwala, Shushu Zhao, Candice Ionescu, Alfredo Perales-Puchalt, Elizabeth M Parzych, Xizhou Zhu, Ali R Ali, Joel A Cassel, Rugang Zhang, Michael R Betts, Mohamed Abdel-Mohsen, David B Weiner
Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers. Science advances 9 (44) (2023)
Sunil Singhal, Jason E Stadanlick, Michael J Annunziata, Abhishek S Rao, Pratik S Bhojnagarwala, Shaun O'Brien, Edmund K Moon, Edward Cantu, Gwenn Danet-Desnoyers, Hyun-Jeong Ra, Leslie Litzky, Tatiana Akimova, Ulf H Beier, Wayne W Hancock, Steven M Albelda, Evgeniy B Eruslanov
Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer. Science translational medicine 11 (479) (2020)